A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma
- 1 July 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (7) , 881-889
- https://doi.org/10.1016/0277-5379(84)90159-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group studyCancer, 1983
- Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas. A report of 131 casesCancer, 1982
- Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variablesCancer, 1982
- Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphomaBlood, 1981
- Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-hodgkin's lymphomaPublished by Elsevier ,1980
- Laparotomy staged I and II non-Hodgkin's lymphomas preliminary results of radiotherapy and adjunctive chemotherapyCancer, 1980
- Nodular malignant lymphomas.Factors affecting complete response rate and survivalCancer, 1979
- Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group studyCancer, 1979
- Survival of patients with localized histiocytic lymphomaCancer, 1977
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975